President Trump announced plans for most-favored-nation pricing on certain drugs in Medicaid programs across all 50 states, aiming to generate $27.6 billion in savings for state governments and $36.6 billion for the federal government over ten years. The announcement was made as part of efforts to highlight Republican achievements ahead of midterm elections; however, some experts doubt the effectiveness and scale of…
White House claims drug pricing progress (this article)2 articles from Semafor on this story
